Clinical association of serum interleukin-17 levels in systemic sclerosis: Is systemic sclerosis a Th17 disease?
Maki Murata(Kanazawa University), Shinichi Sato(University of Tokyo Hospital), Minoru Hasegawa(University of Fukui), Yasuhito Hamaguchi(Kanazawa University), Takashi Matsushita(Kanazawa University), Manabu Fujimoto(Osaka Gakuin University), Kazuhiko Takehara(Kanazawa University), Kazuhiro Komura(Kanazawa University)
Cited by 117
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438